Indivior Pharmaceuticals (INDV) Operating Income (2024 - 2026)
Indivior Pharmaceuticals' Operating Income came in at $160 million for Q2 2026, up 122.2% from $72 million a year earlier and up 16.8% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Operating Income (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Operating Income of $421 million, up 92.2% year-over-year; for FY2025, it came in at $262 million, up 589.5% from FY2024.
- Operating Income carries a four-year compound annual growth rate of 5.3% (FY2021 to FY2025).
- Going back by year, Operating Income was $38 million in FY2024, -$152 million in FY2023, -$77 million in FY2022 and $213 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Operating Income in data going back to Q1 2024.
- Year-over-year, Operating Income has increased for four consecutive quarters, with growth averaging 63.3% over the last five quarters.
- Business Quant data shows INDV's Operating Income at $137 million (Q1 2026), $81 million (Q4 2025) and $43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 160.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.00 Mn |
| Mar 31, 2026 | 137.00 Mn |
| Dec 31, 2025 | 81.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 72.00 Mn |
| Mar 31, 2025 | 66.00 Mn |
| Dec 31, 2024 | 46.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | -118.00 Mn |
| Mar 31, 2024 | 75.00 Mn |
API Access
Indivior Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();